SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-104564
Filing Date
2024-09-09
Accepted
2024-09-09 08:21:33
Documents
27
Period of Report
2024-09-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sabs-20240909.htm   iXBRL 8-K 42500
2 EX-99.1 sabs-ex99_1.htm EX-99.1 21009
3 EX-99.2 sabs-ex99_2.htm EX-99.2 11434
4 GRAPHIC sabs-ex99_2s1.jpg GRAPHIC 256549
5 GRAPHIC sabs-ex99_2s2.jpg GRAPHIC 410666
6 GRAPHIC sabs-ex99_2s3.jpg GRAPHIC 583562
7 GRAPHIC sabs-ex99_2s4.jpg GRAPHIC 483448
8 GRAPHIC sabs-ex99_2s5.jpg GRAPHIC 498233
9 GRAPHIC sabs-ex99_2s6.jpg GRAPHIC 377246
10 GRAPHIC sabs-ex99_2s7.jpg GRAPHIC 285457
11 GRAPHIC sabs-ex99_2s8.jpg GRAPHIC 609890
12 GRAPHIC sabs-ex99_2s9.jpg GRAPHIC 371591
13 GRAPHIC sabs-ex99_2s10.jpg GRAPHIC 542976
14 GRAPHIC sabs-ex99_2s11.jpg GRAPHIC 453123
15 GRAPHIC sabs-ex99_2s12.jpg GRAPHIC 434577
16 GRAPHIC sabs-ex99_2s13.jpg GRAPHIC 359019
17 GRAPHIC sabs-ex99_2s14.jpg GRAPHIC 389551
  Complete submission text file 0000950170-24-104564.txt   8575778

Data Files

Seq Description Document Type Size
18 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sabs-20240909.xsd EX-101.SCH 47153
29 EXTRACTED XBRL INSTANCE DOCUMENT sabs-20240909_htm.xml XML 6620
Mailing Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140
Business Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140 305-845-2813
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39871 | Film No.: 241285904
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)